FDA Approves Gemcitabine Intravesical System for Non-Muscle Invasive Bladder Cancer By Ogkologos - September 19, 2025 452 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Cohort 2 of SunRISe-1 study Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR Efficacy and Safety of Adjuvant Pertuzumab, Trastuzumab and Chemotherapy After 6... February 17, 2021 Thinking outside the box to tackle an aggressive children’s cancer September 8, 2021 Better together: improving brain tumour treatment February 13, 2023 Encorafenib, Cetuximab Combination Approved for Metastatic Colorectal Cancer May 8, 2020 Load more HOT NEWS Therapy Rottweiler, known as Dogtor Loki, Is Delivering ‘Hero Healing Kits’... After Breast Cancer Diagnosis, Technology Professor Teaches Computers to Read Mammograms EMA Recommends Extension of Therapeutic Indications for Acalabrutinib Incidence of Colorectal, Breast, Kidney, Pancreatic, and Uterine Cancers is Increasing...
